Todd Sisitsky

Board of Director, ADARE Pharmaceuticals
Biotechnology
CLINICAL RESEARCH
France

Business Expert Clinical Research
Biography

Todd Sisitsky is a Partner of TPG, the global alternative asset management firm. He is the Managing Partner of TPG Capital North America, head of the firm’s global healthcare investing platform, and a member of the firm’s Executive Committee. He has held leadership roles in connection with TPG’s investments in Adare Pharmaceuticals, Aptalis Pharmaceuticals, Biomet, Fenwal Transfusion Therapies, IASIS Healthcare, Surgical Care Affiliates, HealthScope, IMS Health, Immucor, and Par Pharmaceutical. Todd also serves on the board of directors of the global not-for-profit organization, the Campaign for Tobacco-Free Kids, as well as on the Dartmouth Medical School Board of Overseers. Prior to joining TPG in 2003, Todd worked at Forstmann Little & Company and Oak Hill Capital Partners. He received an MBA from the Stanford Graduate School of Business, where he was an Arjay Miller Scholar, and earned his undergraduate degree from Dartmouth College, where he graduated summa cum laude.

Research Intrest

global healthcare